Demonstration of the metaphylactic use of gamithromycin against bacterial pathogens associated with bovine respiratory disease in a multicentre farm trial.

D Baggott, A Casartelli, F Fraisse, C Manavella, R Marteau, S Rehbein, M Wiedemann, S Yoon

Merial, Centre de Recherche de Saint Vulbas, Parc Industriel de la Plaine de l'Aine, Allee des Cypres, 01150 Saint Vulbas, France. derek.baggott@merial.com

The Veterinary record 2011 Mar 5

filter terms:

On five commercial cattle rearing sites across Europe, a total of 802 young cattle at high risk of developing bovine respiratory disease (BRD) associated with the bacterial pathogens Mannheimia haemolytica or Pasteurella multocida and/or Mycoplasma bovis were enrolled into a multicentre, controlled field trial. Half were treated with a single dose of gamithromycin at 6 mg/kg bodyweight by subcutaneous injection and half received an injection of a saline placebo as the control. All animals were observed daily for 14 days for signs of BRD as defined by set criteria. The proportion of metaphylactic preventive treatment successes, defined as animals surviving to day 14 without signs of BRD, in the gamithromycin-treated group (86 per cent) was significantly (P=0.0012) higher than in the saline-treated controls (61 per cent). Morbidity among the treated animals was reduced by 64 per cent compared with the controls.

Citation

D Baggott, A Casartelli, F Fraisse, C Manavella, R Marteau, S Rehbein, M Wiedemann, S Yoon. Demonstration of the metaphylactic use of gamithromycin against bacterial pathogens associated with bovine respiratory disease in a multicentre farm trial. The Veterinary record. 2011 Mar 5;168(9):241